반응식
C[CH2:2][CH2:3][CH2:4][C:5]([OH:20])([C:12]1[CH:13]=[CH:14][C:15](Cl)=[CH:16][C:17]=1Cl)[CH2:6][N:7]1[N:11]=[CH:10][N:9]=[CH:8]1.CC(C(O)(CN1N=CN=C1)CCC1C=C[C:31]([Cl:34])=CC=1)(C)C.CCCC1OC(C2C=CC(Cl)=CC=2[Cl:62])(CN2N=CN=C2)OC1>>[Cl:62][C:4]1([C:5]([OH:20])([CH2:6][N:7]2[CH:8]=[N:9][CH:10]=[N:11]2)[CH2:12][C:13]2[CH:14]=[CH:15][CH:16]=[CH:17][C:31]=2[Cl:34])[CH2:3][CH2:2]1참가 물질
4
실험 절차
Particularly preferred mixtures comprise as azoles, in addition to hexaconazole, tebuconazole, propiconazole, cycproconazole and/or 2-(1-chloro-cyclopropyl)-1-(2-chlorophenyl)-3-1H-(1,2,4-triazol-1-yl)-propan-2-ol, preferably in a ratio by weight to hexaconazole of 1:9 to 9:1.
출처 및 근거
- ORD 기록
- ord-0e7a986fa46f4d0d89f37df57fec35f5
- 출처 데이터셋
- uspto-grants-1999_10
- 특허 번호
- US05972971
연결된 노트
불러오는 중…